Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice

Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

(2015) Massimo Di Maio et al.   JOURNAL OF CLINICAL ONCOLOGY

Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry

(2014) M. W. M. van der Poel et al.   ANNALS OF HEMATOLOGY

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced peripheral neuropathies in hematological malignancies

(2014) Joost Louis Marie Jongen et al.   JOURNAL OF NEURO-ONCOLOGY

Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review

(2014) Floortje Mols et al.   SUPPORTIVE CARE IN CANCER

Living With Advanced But Stable Multiple Myeloma: A Study of the Symptom Burden and Cumulative Effects of Disease and Intensive (Hematopoietic Stem Cell Transplant-Based) Treatment on Health-Related Quality of Life

(2013) Elaine Boland et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study

(2013) Karin Jordan et al.   SUPPORTIVE CARE IN CANCER

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry

(2012) Floortje Mols et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts

(2011) Lonneke V. van de Poll-Franse et al.   EUROPEAN JOURNAL OF CANCER

Management of treatment-emergent peripheral neuropathy in multiple myeloma

(2011) P G Richardson et al.   LEUKEMIA

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

(2010) Kim Cocks et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues

(2010) Michel Delforge et al.   LANCET ONCOLOGY